feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Asian stocks, global market uncertainty

trending

CSK released Rachin Ravindra

trending

Lava Agni 4 India launch

trending

PM Kisan installment released

trending

Shubman Gill travels with team

trending

Sammaan Capital faces CBI probe

trending

New Zealand wins series

trending

Orry summoned in drugs case

trending

Nvidia Q3 earnings preview

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / BC Babies Face Huge RSV Shot Costs

BC Babies Face Huge RSV Shot Costs

18 Nov

•

Summary

  • Infant RSV immunization costs $800-$900 out-of-pocket in B.C.
  • Most Canadian provinces offer the RSV vaccine free to infants.
  • RSV hospitalizations cost nearly $32.5 million annually in Canada.

An immunization for respiratory syncytial virus (RSV) is now accessible in Canada, yet most parents in British Columbia must pay a substantial price out-of-pocket. Nirsevimab, known as Beyfortus, was approved in April 2023 and recommended for all infants during their first RSV season. While available for $800 to $900, its coverage is limited in B.C., Alberta, and New Brunswick, with only specific high-risk infants or those in remote communities qualifying for public funding.

RSV typically causes mild cold symptoms but can lead to severe illness in newborns and vulnerable populations. A study revealed that infants under six months accounted for nearly 45% of RSV-related hospital admissions in Canada. This highlights the significant risk to young infants who cannot effectively combat the virus, leading to frequent hospitalizations and considerable healthcare costs, estimated at around $32.5 million annually.

The National Advisory Committee on Immunization recommended prioritizing coverage for higher-risk infants due to the vaccine's high price, while also advocating for a universal program. Provinces ultimately decide on medication coverage. The B.C. Ministry of Health stated they review eligibility annually, with 4,000 doses allocated for high-risk infants for the upcoming season, while advocating for broader provincial coverage could prove economically beneficial.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The nirsevimab vaccine, also known as Beyfortus, costs between $800 and $900 out-of-pocket for infants in British Columbia.
British Columbia, Alberta, and New Brunswick are the provinces where the infant RSV vaccine is not universally covered.
RSV can cause severe illness in newborns, leading to hospitalization. The immunization is highly effective at preventing serious RSV complications in infants.

Read more news on

Healthside-arrow

You may also like

Gavi's 3-Year Vaccine Drive Prevents 1.4 Million Cervical Cancer Deaths

17 Nov • 31 reads

article image

Flu Season Ramps Up in 2025, Experts Urge Vaccination

17 Nov • 10 reads

article image

B.C. Sees Uptick in Flu, COVID-19, and RSV Vaccinations Ahead of Illness Season

16 Nov • 7 reads

Manitoba Measles Cases Surge to 249 as Elimination Status Lost

15 Nov • 19 reads

article image

Senator Cassidy Warns Against Changing Hepatitis B Vaccine Schedule

16 Nov • 5 reads

article image